(Received for publication November 22, 1999) In the course of our screening for antitumor antibiotics, two novel compounds, UCS1025A
and B, were isolated from Acremonium sp. KY4917.
UCS1025A exhibited antimicrobial activity, and antiproliferative activity against humantumor cell lines. In this paper, we describe the taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities ofUCS1025A and B. The cultural and taxonomical characteristics of the producing fungal strain KY4917 were as follows. Colonies on 2% malt extract agar medium are 28 to 31mmin diameter after culturing at 25°C for 2 weeks. The surface of the colony is grayish brown at the center and beige or grayish white at the margin. The color of the reverse of the colony is reddish brown at the center and grayish brown at the margin. Soluble orange pigment is produced in the medium. Colonies on Potato-glucose agar medium are about 25mm in diameter after culturing at 25°C for 2 weeks. The color of the colony surface is cream or pale brown at the center and gray at the margin. The color of the reverse of the colony is pale brown to brown at the center and grayish white at the margin. Co. Ltd.) 0.5% in deionized water (pH adjusted to 6.5 with NaOHbefore sterilization). The inoculated flasks were incubated on a rotary shaker at 25°C for 6 days. Fifteen ml of the seed culture were added to a 2-liter Erlenmeyer flask containing 300 ml of the same medium. After incubation on a rotary shaker at 25°C for 2 days, nine hundred ml of seed culture was transferred into each of two 30-liter fermenters containing 1 8 liters of a fermentation medium composed of glucose 2%, dried mashed potato 2%, peptone (Kyokuto Co. Ltd.) 0.5%, KH2PO4 0.5%, Mg3(PO4)2à"7H2O in deionized water (pH adjusted to 6.0 with NaOH before sterilization). The fermentation was carried out at 25°C for 7 days with agitation of 300rpm and aeration of 18 liters per minute.
The 30 liters of culture broth was filtered using a centrifugal filter and the filtrate was applied to a column of Diaion HP-20 (2 liters, Mitsubishi Chemical Industries).
The column was washed with 40%MeOHand then the active substance was eluted with MeOH(6 liters). The eluate was concentrated and extracted with AcOEt. The extract was concentrated in vacuo to yield a brown oil. The oil was applied to a column of silica gel WakogelC-200 (WakoPure Chemical Industries). The column was washed with hexane-AcOEt (7 : 3) and the active substance was eluted with hexane-AcOEt (6:4). The eluate was concentrated in vacuo and then applied to a column of silica gel LiChroprep Si 60 (Merck). After the column was washed with hexane-acetone (86 : 14), UCS1025A and B The physico-chemical properties of UCS1025Aand B are summarized in Table 1 . The structures of UCS1025A and B were elucidated by the spectroscopic analysis and the X-ray crystallography (Fig. 1) . UCS1025A turned out to be a novel natural product which was constituted from two segments. One of them was an unique tricyclic skeleton including a pyrrolizidine fused with a 7-lactone and another was a decaline moiety. On the other hand, UCS1025B contained a mono-oxidized tricyclic skeleton and the decaline moiety. Antitumor compounds clazamycin A and B from Streptomyces puniceus2^and antimicrobial compoundspyrrolam A~Dfrom Streptomyces olivaceus3ĥ ave been isolated as the antibiotics containing a pyrrolizidine moiety. HoweverUCS1025A belongs to a distinct class from these reported antibiotics because UCS1025A possesses the unique pyrrolizidine skeleton. The details in the structure determination of UCS1025A and B will be reported elsewhere. The antimicrobial activities of UCS1025A and B are shown in at the concentration up to 100^m, suggesting the structural difference in the tricyclic skeleton between UCS1025A and UCS1025B affect their biological activities. Detailed studies on the mechanismof action and antitumor activity ofUCS1025A and B are in progress.
